B cells and plasma cells possess distinct RNA processing environments that respectively promote the expression of membrane-associated Ig by B cells versus the secretion of Ig by plasma cells. Through a combination of transcriptional profiling and screening using a lentiviral short-hairpin RNA interference library, we show that both the splicing factor hnRNPLL and the transcription elongation factor ELL2 modulate the ratio of secreted versus membrane-encoding Ighg2b transcripts in MPC11 plasmacytoma cell lines. hnRNPLL and ELL2 are both highly expressed in primary plasma cells relative to B cells, but hnRNPLL binds Ighg2b mRNA transcripts and promotes an increase in levels of the membrane-encoding Ighg2b isoform at the expense of the secreted Ighg2b isoform, whereas ELL2 counteracts this effect and drives Ig secretion by increasing the frequency of the secreted Ighg2b isoform. As in T cells, hnRNPLL also alters the splicing pattern of mRNA encoding the adhesion receptor CD44, promoting exon inclusion, and decreasing the overall level of CD44 expression. Further characterization of ELL2-dependent transcription by RNA-Seq revealed that ∼12% of transcripts expressed by plasma cells were differentially processed because of the activities of ELL2, including B-cell maturation antigen BCMA, a receptor with a defined role in plasma cell survival. Taken together, our data identify hnRNPLL and ELL2 as regulators of pre-mRNA processing in plasma cells.
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immunoglobulin | mRNA splicing | transcriptional elongation | B cell maturation antigen O ne of the earliest examples of a single gene encoding multiple transcripts and protein species was provided by genes encoding the Ig heavy chain (IgH) (1) (2) (3) . The discovery that the IgH genes are alternatively processed at their 3′ ends explained how they could generate transcripts encoding both membrane-associated and secreted Ig, with B cells primarily expressing the former and plasma cells the latter. The levels of membrane-encoding and secreted IgH transcripts are controlled by the mutually exclusive use of a splice site versus a cleavage/polyadenylation [poly(A)] site at the 3′ end of the IgH pre-mRNA transcript (see diagram in Fig.  1A ). In IgG-expressing B cells, the C H 3 exon (or, in IgM-expressing B cells, the C H 4 exon) is spliced to downstream M1 and M2 exons encoding the transmembrane and cytoplasmic domains of membrane Ig (mIg), respectively, with the membrane-associated poly(A) [mbp(A)] site used. In plasma cells, a weak poly(A) sequence [secp (A)] located downstream to the C H 3 exon is included in the final mRNA transcript, with recognition of the secp(A) producing a truncated transcript encoding secreted Ig (sIg) (4, 5) . B cells express nearly equivalent levels of sIgH and mIgH transcripts; upon antigen-driven activation and differentiation into plasma cells, sIgH transcripts are overwhelmingly increased in frequency (5, 6) . Overall, therefore, the B-cell mRNA processing environment is tilted toward enhanced mRNA splicing at the expense of the cleavage/polyadenylation reaction (7) (8) (9) . In contrast, the plasma cell mRNA processing environment is tilted toward enhanced cleavage/polyadenylation processing of pre-mRNA (8, 10) . It is likely that these distinct mRNA processing environments reflect the differential presence, in B cells versus plasma cells, of RNA processing factors operating in trans on IgH pre-mRNA (5, 8) .
To identify modulators of pre-mRNA splicing in B cells, we combined transcriptional profiling and a lentiviral shRNA screen to identify RNA-binding proteins that controlled the processing of IgH mRNA. We identify the splicing factor hnRNPLL (heterogeneous ribonucleoprotein L-like) and confirm the role of elongation factor RNA polymerase II, 2 (ELL2) in IgH premRNA processing (11) , and demonstrate that ELL2 is a global regulator of the plasma cell transcriptome.
Results

Microarray Analysis Identifies Differentially Expressed Factors with
Predicted mRNA Splicing Function in B Cells and Plasma Cells. Because the distinct mIgH/sIgH transcript ratios in B cells and plasma cells are controlled by transcriptional regulators differentially expressed between these two cell types (reviewed in ref. 8) , we hypothesized that factors involved in differential processing of IgH premRNA in B cells and plasma cells were present in the subset of splicing regulators differentially expressed in these two cell types. To this end, we compared, by microarray, the transcriptional profiles of purified naive mature B cells (B220
) and bone marrow resident plasma cells (B220 − CD138 + ). A list of differentially expressed genes between B cells and plasma cells (twofold change, false-discovery rate 1%) was generated and compared with a list of 307 proteins previously implicated in regulation of pre-mRNA splicing, including members of the serine/argentine rich (SR) and hnRNP families, transcription elongation factors, and SR protein kinases, as well as other proteins containing RNA-recognition motifs.
Within the list of predicted splicing factors, we identified 51 genes (represented by 78 probes), the transcripts of which were differentially expressed between B cells and plasma cells, with 30 genes represented in plasma cells and 21 represented in B cells (Fig. S1A) . Among the genes whose transcripts were most highly expressed in plasma cells were Rbm47, Hnrpll (which encodes the hnRNP family member hnRNPLL), the SR protein Srsf17b, and the elongation factor Ell2; the genes most highly expressed in B cells included the elongation factor Ell3 and the SR protein kinase Srpk3 (Fig. S1A ). Based on these data, we designed a limited shRNA screen to test whether one or more of these factors might modulate IgH alternative splicing.
Expression of hnRNPLL by Plasma Cells. We previously demonstrated that hnRNPLL regulates the alternative splicing of CD45 pre-mRNA in T cells (12) . Given the heightened expression of Hnrpll trancripts in plasma cells, as indicated by our microarray data as well as public microarray databases (GDS1695), we investigated the expression and functional role of hnRNPLL in plasma cells. Indeed, a mouse plasmacytoma cell line, MPC11, expressed 10-fold higher amounts of Hnrpll transcripts compared with the A20 B lymphoma cell line (Fig. S1B ). To examine hnRNPLL protein expression, we generated an affinity-purified polyclonal antiserum against a peptide at the N terminus of hnRNPLL (Fig. S2A) . Two hnRNPLL bands (65 and 80 kDa) were observed in immunoblots of MPC11 cell lysates with the anti-hnRNPLL antiserum ( Fig. S1 C and E): the more abundant 65-kDa isoform corresponds to the predicted molecular weight of hnRNPLL based on published protein sequences (National Center for Biotechnology Information Ref Seq NP_659051.3).
We also examined Hnrpll mRNA and protein expression by in vitro-activated murine CD4 T cells and B cells. Naive CD4 T cells express Hnrpll mRNA, with transcript levels doubling upon 72 h of activation with anti-CD3/CD28 (Fig. S1D) ; there was little change in hnRNPLL protein levels (Fig. S1E) . Even though we could not detect expression of Hnrpll by naive B cells, B cells activated for 72 h by various conditions expressed detectable levels of Hnrpll mRNA transcripts, although at greatly diminished levels compared with naive or activated T cells (Fig.  S1D) . The low expression of hnRNPLL by activated B cells was also evident at the protein level (Fig. S1E) .
Sorted B220 − CD138 + plasma cells exhibited an ∼20-fold increase in Hnrpll transcript levels compared with B220 + B cells (Fig. S1F) , and observed heightened expression of hnRNPLL by intracellular staining in the plasma cell population compared with total B220 + B cells (Fig. S1G) . We also examined the expression pattern of hnRNPLL in CD4 + T cells, with CD4 (Fig. S2B) , consistent with higher hnRNPLL expression by human activated/memory T cells (12) . Antibody specificity was verified by decreased hnRNPLL staining upon shRNA-mediated knockdown of hnRNPLL in MPC11 cell lines (Fig. S2C) . Taken together, these data confirm that hnRNPLL is expressed at the protein level in plasma cells.
hnRNPLL Directly Associates with and Influences the Splicing Fate of IgH and CD44 Pre-mRNA Transcripts. The heightened expression of hnRNPLL by plasma cells in comparison with B cells, and the opposing abilities of these respective cell types to process IgH mRNA, prompted us to examine the potential role of hnRNPLL in IgH pre-mRNA processing. Using the MPC11 plasmacytoma cell line, we developed a quantitative RT-PCR (qRT-PCR)-based assay that quantifies the relative amounts of membrane associated (mIghg2b) and secreted (sIghg2b) Ighg2b transcripts using a common primer situated on the C H 3 exon of Ighg2b (forward primer) and reverse primers situated either on the cassette exon containing the secp(A) site (sIgH reverse primer) or the Ighg2b M1 exon (mIgH reverse primer) (Fig. 1A) . Based on this assay, we estimated the basal sIghg2b:mIghg2b ratio to be 45:1 in MPC11 cells, a ratio consistent with previous data on plasmacytoma cell lines (4) . To deplete hnRNPLL protein in MPC11 cells, we transduced MPC11 cells with pLKO.1 lentivirus encoding short hairpins (shRNAs) that target Hnrpll transcripts. After eliminating untransduced cells by selection with puromycin, we achieved ∼80% knockdown of Hnrpll mRNA transcripts and almost complete depletion of hnRNPLL protein in cells transduced with LV-hnRNPLL-shRNA#2, compared with cells transduced with empty pLKO.1 vector or a vector encoding a hairpin specific to GFP ( Fig. 1 B and C) . hnRNPLL depletion in MPC11 cells was associated with a twofold reduction in the ratio of mIghg2b to sIghg2b mRNA (Fig. 1D) . These results suggested that depletion of hnRNPLL in MPC11 cells increased utilization of the secp(A)-containing cassette exon.
We next asked whether hnRNPLL directly associated with Ighg2b mRNA in MPC11 cells. We used RNA-immunoprecipitation-that is, hnRNPLL immunoprecipitation followed by qRT-PCR-to quantify Ighg2b mRNA transcripts bound to hnRNPLL. We additionally tested for the presence of Cd44 mRNA transcripts, a known target of hnRNPLL in T cells (12) , in hnRNPLL immunoprecipitates. Compared with immunoprecipitates prepared with control IgG, hnRNPLL immunoprecipitates showed strong enrichment for both Cd44 and Ighgh2b mRNA transcripts ( Fig. 1 E and F) . To precisely identify the hnRNPLL binding sites within Ighg2b transcripts, we performed photoactivatable-ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP) (13) (Fig. 1G) . A feature of PAR-CLIP is that cross-linked RNAs can be distinguished from contaminating or spurious noncross-linked RNAs by a discernible increase in the frequency of T > C transitions at the sites of RNA-protein cross-linking when using 4-thiouridine, with this feature used to distinguish true RNA partners for a given protein, and moreover experimentally pinpoints sites in the vicinity of RNA-protein cross-links (13) . Based on the presence of T > C transitions, major peaks of hnRNPLL binding were identified within the H and C H 2 exons of Ighg2b, with peaks observed in the C H 1, H, C H 2, and M2 exons (Fig. 1G) . Taken together, these data demonstrate that hnRNPLL modulates Ighg2b pre-mRNA processing and facilitates secp(A) exon exclusion through direct association with Ighg2b pre-mRNA. Consistent with our previous findings that hnRNPLL promotes Cd44 exon exclusion in T cells (12) , we observed that depletion of hnRNPLL promoted exon retention in MPC11 cells (Fig. 2B) , as assessed by RT-PCR analysis using primers bookending the Cd44 cassette exons (Fig. 2A) . In addition, increased Cd44 transcript and CD44 protein levels were observed upon hnRNPLL depletion (Fig. 2 C and D) . Through analysis of reads with T > C transitions that aligned to the Cd44 locus after hnRNPLL PAR-CLIP, we identified multiple hnRNPLL binding sites within the intervening introns of the Cd44 cassette exons (Fig. 2E) , as well as within exon 1. These results indicate that hnRNPLL directly associates with Cd44 pre-mRNA transcripts and modulates both the alternative splicing of Cd44 pre-mRNA and the expression levels of CD44 protein.
Lentiviral shRNA Screen Confirms ELL2 as a Regulator of Ig Processing in Plasma Cells. The results described in Fig. 1 indicated that hnRNPLL drives expression of mIg at the expense of sIg, thus unexpectedly countering rather than promoting Ig secretion by plasma cells. This finding implied that other trans factors expressed in plasma cells dominantly counteract this function of hnRNPLL and drive production of the sIgH isoform. To identify these factors, we performed a lentiviral shRNA screen in the IgG2b-secreting MPC11 plasmacytoma cell line and the IgG2a-expressing A20 B lymphoma cell line, focusing on the candidate targets most strikingly differentially expressed in either plasma cells (24 of 30 targets were pursued) or B cells (12 of 21 targets were pursued). The levels of mIgH and sIgH in MPC11 and A20 cells were quantified using the qRT-PCR method presented in Fig. 1 ; combined primary and secondary screening data are shown in Fig. 3 A and B. Three hairpins targeting the ELL2 protein increased the ratio of mIghg2b to sIghg2b in MPC11 cells (Fig. 3A) . No significant hits were observed in the B-cell screen (Fig. 3B) .
We examined the expression patterns of candidates in A20 and MPC11 cell lines. Consistent with the expression patterns observed in primary cells (Fig. S1A) (Fig. S3) . ELL2 was previously identified as a protein capable of driving sIgH accumulation in plasma cells (11) . By qRT-PCR, we observed that several activation conditions (72 h) induced Ell2 transcript accumulation in B cells; in contrast, CD4 T cells showed no changes in transcript levels upon activation with anti-CD3 and anti-CD28 (Fig. 3C) . Moreover, plasma cells sorted ex vivo exhibited an approximately fivefold increase in mRNA transcript levels compared with naive mature B cells (Fig. 3D) . To confirm the role of ELL2 in IgH pre-mRNA processing, we depleted Ell2 transcripts in MPC11 cells. When the two best hairpins, ELL2-1C7 and ELL2-1C11, were transduced into MPC11 cells, in each case depleting Ell2 transcripts by at least 80% (Fig. 3E) , a fourfold increase in levels of mIghg2b mRNA relative to sIghg2b was observed (Fig. 3F ). This increase of mIghg2b relative to sIghg2b was the result of a twofold increase in mIghg2b levels and a twofold decrease in total sIghg2b levels (Fig. 3G) . Finally, the reduction in sIghg2b transcript levels resulting from ELL2 knockdown resulted in a concomitant reduction in the amount of Ig secreted by the MPC11 cell line (Fig. 3H) . Taken together, these data validate ELL2 as modulating IgH mRNA processing and implicate ELL2 as necessary for optimal Ig production and secretion by plasma cells.
Global Identification of ELL2-Dependent mRNA Processing Events. To test whether ELL2 regulates a broad program of pre-mRNA processing in plasma cells, we performed RNA-sequencing on MPC11 cell lines transduced with either pLKO.1-shGFP (hereafter referred to as shGFP) or pLKO.1-shELL2-1C7 (referred to as shELL2) lentiviruses. For the shGFP and shGFP samples, 203 and 243 million reads were generated, of which 66% and 70%, respectively, mapped to the genome. Of reads mapping to the genome, 40% mapped to exons for the shGFP samples and 39% mapped to exons for the shELL2 samples, with 3 million and 3.9 million reads aligning to splice junctions or alternative exons for the shGFP and shELL2 samples, respectively. Manual inspection of reads aligning to Ell2 exons confirmed successful depletion of Ell2 transcripts in the shELL2 compared with the shGFP MPC11 cell line (Fig. S4A) , in contrast to similar frequencies of reads aligning to the Gapdh and Actb gene bodies (Fig. S4 B and C) . Negative binomial-based differential expression analysis (14) pointed to a 10-fold decrease in expression of Ell2 transcripts (corrected P value of 1.23E-09). Expression levels of Ighg2b transcripts were similarly analyzed using both a gene-and an exon-centric approach. Upon ELL2 depletion, reads aligning to the entire gene body of Ighg2b were reduced twofold (P = 0.013) (Fig. S4D) . When the expression levels of each exon were compared between the two treatment groups, we observed a consistent twofold loss of expression of the C H 1, C H 2, and C H 3 exons (Table S1 ). Conversely, reads aligning to the M1 and M2 exons in the shELL2 samples were increased, although not statistically significantly, with fold-change increases of 1.52 (P = 0.17) and 2.15 (P = 0.46), respectively (Table  S1 ). This twofold decrease in sIghg2b transcripts and twofold increase in mIghg2b transcripts observed upon ELL2 depletion is in agreement with our qRT-PCR data (Fig. 3G) .
The RNA-Seq data were used to assess how ELL2 controls the expression patterns of alternative transcript isoforms at the transcriptome level. We used the mixture-of-isoforms (MISO) model to estimate expression levels of different mRNA isoforms (15) by quantifying the presence of alternatively spliced exons and 3′ poly(A) sites residing on UTRs, using significance thresholds of Bayes Factor > 10 and RPKM > 1 (reads per kilobase per million reads). This methodology allowed us to: (i) identify targets for which ELL2 modulates the following premRNA processing event subclasses: tandem 3′ UTRs, mutually exclusive exons, skipped exons, alternative 3′ and 5′ splice sites, retained introns, and alternative first and last exons (depicted in Fig. 4A) ; and (ii) query whether ELL2 depletion led to preferential inclusion or exclusion of alternative exons and UTRs. We calculated the "percent spliced in (Ψ)" value for cassette exons and UTRs in the shGFP and shELL2 samples (15) . We observed significant changes in mRNA processing in each type of event subclass analyzed, with exons and UTRs preferentially included as well as excluded upon ELL2 depletion (Fig. 4B) . In total, of 10,376 transcripts annotated, 1,248 transcripts (12% of total) were differentially processed upon ELL2 depletion, indicating a broad role for ELL2 in regulating mRNA processing events in plasma cells. Many genes were found to undergo multiple types of differential splicing events ELL2 depletion (Dataset S1) and, in addition, to undergo two or more differential splicing event classes. Taken together, these results indicate widespread changes in mRNA processing occurring as a result of ELL2 depletion in plasma cells. We determined the directionality of exons and UTR exclusion versus inclusion in transcripts whose alternative splicing and tandem UTR use were influenced by ELL2. To quantify this determination, we calculated ΔΨ, the difference in Ψ values for each type of splicing event between the shGFP and shELL2 samples. A ΔΨ > 0 indicates a preference for cassette exon or UTR inclusion, whereas a ΔΨ < 0 indicates a preference for cassette exon or promoter distal UTR exclusion upon ELL2 depletion. For all splicing event subclasses, we observed a nearly equal frequency of events where exons were included versus excluded (Fig. 4B) . Despite the high frequency of differentially occurring mRNA processing events resulting from ELL2 depletion, a statistically significant directional bias was not observed for any event subclass as the mean of ΔΨ did not significantly deviate from 0 (Fig. 4C) . Fig. 4C also shows that the ΔΨ values for alternative last exon events modulated by ELL2 deviated significantly from those observed for all other subclasses of pre-mRNA processing events (significance determined by ANOVA with Bonferroni posttest, P < 0.001), indicating that splicing events involving the last exon are significantly less influenced by ELL2 depletion compared with other subclasses of splicing events. In summary, we conclude that despite the high frequency of transcripts whose processing is modulated by ELL2 and the clear effect of ELL2 depletion on secp(A) exon exclusion and tandem UTR use at the Igh locus, we do not observe an overt directional bias imposed on specific subclasses of premRNA processing events at the transcriptome level.
We additionally performed GeneTrail Advanced Gene Set Enrichment Analysis (GSEA) to examine whether transcripts modified by ELL2 were enriched for particular functional categories. A number of subcategories were significantly enriched (Table S2 ). The top category was the spliceosome, with many core and regulatory components (including members of the SR and hnRNP families) as well as components of the transcription/ export (TREX) complex found affected by ELL2 depletion. Transcripts encoding proteins involved in the RNA degradation pathway were also strongly regulated by ELL2, including components of the deadenylase complex and the exosome. Many components of the ribosome were also targeted by ELL2. Finally, ELL2 also modified protein-processing pathways as components of the protein export pathway, including sec proteins, and a number of proteins involved in ubiquitin-mediated proteolysis were affected. We conclude from these results that that ELL2 preferentially processes transcripts encoding protein products involved in RNA and protein processing.
ELL2 Is Required for the Expression of B Cell Maturation Protein by
Plasma Cells. We performed differential gene expression (DESeq) analysis to identify changes in overall gene expression levels between shGFP and shELL2 samples. Upon ELL2 depletion, the transcript levels of Tsc22d1, a TGF-β-induced gene, were significantly increased, and those of Tnfrsf17 (encoding the B-cell maturation protein, BCMA, a receptor with a known role in plasma cell function) and Ccnb2 (encoding cyclin B2) were significantly suppressed (Table S1 ). Manual analysis of reads aligning to the Tnfrsf17 locus found that reads corresponding to all three exons were indeed lost upon ELL2 depletion (Fig. 5A) . We validated this finding, as well as the differential transcript levels of Tsc22d1 and Ccnb2, by qRT-PCR (Fig. 5B) . Notably, the expression levels of Tnfrsf17 transcripts were reduced over 20-fold. At the protein level, we were unable to detect BCMA on the surface of MPC11 cells depleted for ELL2 by transduction with shELL2, although shGFP-transduced MPC11 cells expressed detectable levels of BCMA, as shown by flow cytometry (Fig. 5C ). These data demonstrate an essential role for ELL2 in driving the expression of BCMA in plasma cells. The model that emerges from these collective data are a plasma cell gene regulatory network that incorporates ELL2 and hnRNPLL as pre-mRNA modulating factors that function downstream of the transcriptional regulators driving the plasma cell state, with Blimp1 controlling hnRNPLL expression and IRF4 controlling ELL2 expression (16, 17) . These factors, hnRNPLL and ELL2, contribute to the plasma cell state by controlling the pre-mRNA processing of network of transcripts, including those encoding Ighg2b and BCMA (Fig. 5D ).
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Discussion
A growing body of evidence supports the concept that cellular growth, survival, differentiation, and apoptosis are regulated by factors controlling pre-mRNA processing. In many cases, a single factor controls the differential processing of an entire network of gene products and can function as a regulatory switch both at the cellular and organism level (18, 19) . Our presented study identifies and characterizes hnRNPLL and ELL2 as expressed in plasma cells, with both proteins regulating the processing of multiple mRNA targets and, by regulation of IgH, CD44, and BCMA plasma cell function.
Through an shRNA screen in T cells, we identified hnRNPLL as a major regulator of CD45 pre-mRNA processing (12) . It is apparent that the influence of hnRNPLL on T-cell function goes beyond its ability to facilitate exon exclusion in CD45 pre-mRNA transcripts (12, 20) , as indicated by the effect on processing of diverse target mRNAs in activated T cells (12, 20) , and because breeding a mouse strain harboring a hnRNPLL V136D mutation onto a CD45-deficient background did not mitigate the functional impact of the hnRNPLL V136D mutation on in vivo T-cell survival and homeostasis (21) . In plasma cells as in T cells (12) , hnRNPLL regulates the alternative splicing of CD44 premRNA, indicating an overlap of targets between these two cell types. In plasma cells, we show here that hnRNPLL directly associates with IgH mRNA, and that ablation of hnRNPLL leads to increased recognition of the weak secp(A) site and heightened accumulation of the sIgH isoform. The role hnRNPLL plays in plasma cell function in vivo remains to be defined.
Using an approach similar to the one we employed to identify hnRNPLL as a regulator of CD45 pre-mRNA splicing (12), we used a candidate shRNA-lentiviral screen on B-cell and plasma cells lines to screen for factors modulating IgH pre-mRNA processing. Our data confirm previous work by Milcarek and colleagues (11) , who demonstrated that the transcription elongation factor ELL2 was highly expressed and able to enhance IgH exon skipping and polyadenylation in plasma cells.
To analyze further how ELL2 functions in plasma cells and define its influence on the overall plasma cell transcriptome, we performed RNA-Seq on a plasmacytoma cell line in which ELL2 expression had been silenced by shRNA. It was clear from our RNA-Seq analysis that ELL2 modified the processing of a broad number of transcripts. Notably, ELL2 depletion did not particularly bias the plasma cell pre-mRNA cleavage/ polyadenylation/ splicing environment toward increased exon skipping or promoter-proximal tandem UTR use. The directional bias observed at the IgH gene, and the absence of this bias at the broader transcriptome level, may reflect an exquisite sensitivity of IgH pre-mRNA to modest changes in the splicing environment, resulting from the mutually exclusive nature of the cleavage/ polyadenylation and splicing reaction and the weak secp(A) and 5′ splice sites (8) . For example, separation of the tandem poly(A) sites of the IgH gene from the competing splice reaction and introduction of these IgH minigenes into B-cell and plasma cell lines resulted in an increase in sec(A) site use by only twofold in plasma cells compared with B cells (8, (22) (23) (24) . Similarly, separation of the IgH gene splicing reaction from the cleavage/polyadenylation reaction by use of minigenes, and subsequent introduction of these constructs into B-cell and plasma cell lines resulted in greater rates of splicing by B-cell lines (7) . However, the researchers went to great lengths to generate a minigene sensitive enough to detect this difference: to observe and amplify the difference in splicing environments, a weakened 5′ splice site had to be used (7) . Furthermore, previous attempts to identify splicing environment differences between B cells and plasma cells yielded inconclusive results, indicating that the assays that were used were not sensitive enough to detect these differences (24, 25) . Given the sensitivity of the IgH gene to changes in cleavage/polyadenylation and splicing environment, it is not surprising that we did not observe any overt directional bias in splicing or tandem UTR use at the transcriptome level in our RNA-Seq results.
Our finding that ELL2 is required for the expression of BCMA directly links ELL2 to in vivo plasma cell function. BCMA (encoded by Tnfrsf17) is selectively expressed by plasma cells within the B-cell lineage, and upon engagement with its ligands BAFF and APRIL in the context of a prosurvival environmental niche, BCMA provides plasma cells with critical survival signals enabling their long-term persistence in the host (26, 27) . In the absence of BCMA expression, the establishment of long-lived plasma cells in the bone marrow is defective, leading to impaired long-term humoral memory (27) . How ELL2 is so dramatically required for the expression of BCMA, and whether this effect is direct, remains to be mechanistically elucidated. The ablation of BCMA expression upon depletion of ELL2 in cell lines hints at an essential role for ELL2 in plasma cell survival in an in vivo setting. In summary, we have shown that both hnRNPLL and ELL2 are mediators of pre-mRNA processing in plasma cells.
Materials and Methods
Cell Culture and Lentivirus Transductions. Viruses were obtained from The RNAi Consortium (TRC) at The Broad Institute (28) . LV-hnRNPLL-2 corresponds to TRCN0000123505, ELL2-1C7 to TRCN0000188411, and ELL2-1C11 to TRCN0000353318.
Generation of an Anti-hnRNPLL Polyclonal Antibody. Rabbit antiserum was raised against the peptide KSQAKRLKTEEGEIVYSAEC.
qRT-PCR, Microarrays, and Microarray Analysis. RNA was purified using the Qiagen RNeasy Mini kit, with qRT-PCR performed using SYBR green (Applied Biosystems) on a StepOne Plus (Applied Biosystems). Primers are listed in Table S3 . RNA from B220 Generation of MPC11 Cell Lines, RNA-Seq, and PAR-CLIP. RNA-Seq data were deposited in the Gene Expression Omnibus database under accession no. GSE40285. PAR-CLIP experiments were conducted as previously described (13), with recovered RNA fragments sequenced using a SOLiD4 sequencer and aligned to the mouse genome (mm9) with Bowtie. Further methods are included in the SI Materials and Methods. 
